Is Mounjaro Accessible Through the NHS? Here’s What You Need To Know

Summary Overview

• According to the NHS, from 23 June 2025, Mounjaro (tirzepatide) is accessible via the NHS for individuals dealing with obesity and other weight‑related health conditions.
• Up to date, in order for you to be eligible for it, it requires you to have a high BMI and at least have 4 out of 5 qualifying comorbidities which includes type 2 diabetes, high blood pressure, heart disease, dyslipidaemia, sleep apnoea
• This is in a roll‑out phase. First is through a specialist weight management service then gradually accessible into primary care.

 

What You Need To Know

By the end of the article, you will learn the following:

• You will learn to understand how Mounjaro (tirzepatide) works and what it is about. You’ll also learn how it works for treating diabetes & weight loss.
• You will learn to know the current NHS eligibility criteria such as BMI thresholds, comorbidities, phased rollout, and ethnic adjustments.
• You will learn to be able to compare how the NHS access differs with private access / alternatives.

 

What You Need To Know About Mounjaro?

Mounjaro or tirzepatide is a considered as the first-in-class medication which is known as a dual GIP and GLP-1 receptor agonist. Compared with other similar medicines like Ozempic which only target one hormone, Mounjaro targets two hormones making it a dual-action medication. It works by mimicking two naturally occurring gut hormones:

• GLP-1: It is about slowing down your stomach and sending a signal to your brain that you are already full.
• GIP: It is about helping the body break down sugar and fat more efficiently. It may also even reduce the feeling of nausea which is often felt with GLP-1 medicine alone.

 

As of 2026, Mounjaro has already several primary approved uses which are the following:

• Type 2 Diabetes: The FDA approved this in order to help individuals lower blood sugar.
• Weight Management: While the brand Mounjaro is specifically for treating diabetes, the same exact medicine is also sold under the name Zepbound which is specifically for chronic weight management in adults dealing with obesity or people who are overweight with health issues such as high blood pressure.
• Sleep Apnea: This was recently approved last 2024 in treating sleep apnea with moderate-to-severe obstructiveness in patients dealing with obesity.

 

How Mounjaro Works For Weight Loss

Mounjaro works by treating weight loss as a biological issue instead of just willpower. But through the activation of both GIP and GLP-1 receptors, it does the following:

• Reduces Your Food Noise: It helps in reducing the constant food noise that makes you crave for more food.
• Delays Gastric Emptying: It helps in keeping the food in your stomach stay longer and extending the feeling of fullness despite having a few food intake.
• Improves Your Insulin Sensitivity: It works by helping your cells respond better to insulin which can actually change how your body is storing fat.

Mounjaro is also currently considered as one of the most powerful weight-loss medications on the market today. These data is according to the major clinical trials such as the SURMOUNT studies:

• Average Loss: People who are taking Mounjaro on the highest dose like 15 mg are reported to have lost an average of 20% to 22.5% of their body weight over 72 weeks of use.
• Comparison: People who are taking high-dose Mounjaro is consistently outperforming Ozempic weight loss trials.
• Long-Term Effect: According to studies, it shows that in order to keep the weight off, the majority of the people would need to stay on the medication long-term. Because stopping might often lead to weight gain.

The Side Effects & Safety Considerations of Mounjaro

Because Mounjaro job is to focus more on the digestive system, most of its side effects are generally gut-related like the following:

• Common side effects: You might experience nausea, diarrhea, decreased appetite, vomiting, and constipation during the first few weeks of taking it. These are only temporary as your body adjusts and these are typically the strongest when you first start or increase your dose.
• Serious but mostly rare: You might experience Pancreatitis, gallbladder problems, and kidney issues. It is best to consult with your clinic immediately if there is persistent pain beyond the standard phase.

 

 

Is Mounjaro Accessible Through the NHS?

The National Institute for Health and Care Excellence issued several updates in late 2023 and throughout 2024 which officially recommended Mounjaro for use within the NHS. It was initially approved strictly only for people managing Type 2 Diabetes, however in the 2026 guidance, it now includes its use for chronic weight management but should be under specific conditions.

This significant rollout has moved beyond just specialist weight loss clinics. The demand has become high so the NHS has already begun a phased implementation plan which will allow some primary care (GP) surgeries to actually prescribe it. This will only be applicable if they have the necessary support staff in monitoring the progress of the patients and able to provide sufficient nutritional counselling.

 

What Are The NHS Criteria for Mounjaro

BMI & Ethnicity

In order to qualify for Mounjaro for weight loss on the NHS, there are certain factors you need to meet such as meeting a specific Body Mass Index (BMI) requirements:

• General Threshold: You should have a BMI of 35 or higher.
• Ethnicity Adjustment: For people who are South Asian, Chinese, Black African, or African-Caribbean descent, the threshold should be lowered to 32.5 or higher. The reason for this is these groups are often facing higher health risks at a lower BMI level.

 

You Should Have Existing Comorbidities

Meeting the requirement of high BMI is usually not enough. the NHS also requires you to have at least one weight-related health issue, here are the following health related issue which you’ll need to have:

• Type 2 Diabetes or Pre-diabetes.
• Hypertension
• High cholesterol
• Heart-related issues
• Obstructive Sleep Apnea

 

Phases of Rollout: Who Should Be First?

The NHS cannot provide Mounjaro to everyone all at once, they are currently under the phasing or stages approach such as the following:

• Phase 1: This is the current priority. These are the people with the highest BMIs and people dealing with the most severe health complications.
• Phase 2: This is the stage where the people who have met the standard criteria of 35 BMI criteria with at least one comorbidity.
• Phase 3: This is the stage where it starts to expand to wider groups as the supply and funding allows.

 

Who Is Not Currently Eligible?

While there are list of criterias for eligible individuals for taking Mounjaro, there are also a list of people who are currently not eligible to take it through the NHS:

• If you are only considering it for cosmetic weight loss
• If you are currently pregnant or currently breastfeeding.
• If you have a history of specific thyroid cancers.
• If you are already under another GLP-1 medication

 

Can You Still Get Mounjaro On The NHS for Weight Loss?

Accessing Mounjaro on the NHS has significantly changed over the last year. As of March 2026 it is officially available for weight loss. However, because of the demand and because millions of people are eligible, the NHS is currently implementing the strict phased approach to fully ensure those at the highest risk will be able to get it first.

Yes you can still get it on the NHS but it is restricted to Priority Groups at the moment. The NHS is currently rolling the drug out over a 12-year period. Their goal is to treat about 220,000 people in the first three years of roll out.

The Difference Between Specialist Services and Private Clinics: Compared with private clinics which you can normally pay to get a prescription if your BMI is over 30, the NHS will only provide Mounjaro through a Specialist Weight Management Services or specific Primary Care (GP) programs which have been funded within your local area.

The Postcode Lottery: There is still limited access to it because not every GP surgery in England is ready and able to prescribe it yet. Some are currently setting up the necessary team care while there are about 80% of local health boards (ICBs) which have started the rollout.

Required Support: If you are getting Mounjaro on the NHS, You cannot get it alone on the NHS. In order for you to stay on the prescription, you are required to participate in a lifestyle support programme which includes the following:

• You must undergo a reduced-calorie diet plan.
• You must Increase your physical activities.
• You need to monitor your weight and side effects monthly.

 

Conclusion

The availability of Mounjaro on the NHS in 2026 plays a major turning point in how obesity is treated. However, because there is a huge demand for it in the market and the rollout is currently under strict phases, you definitely need to have patience in getting it. But the most important thing to note is that these medications are only tools and not the actual cures. They will only work best if you will pair it with a long-term commitment to a healthy lifestyle and healthy diet plan.